HTAi 2021 Virtual Annual Meeting: Weekend Recap and Intro to Day One


We’ve officially made it to Day One of the 2021 Annual Meeting! 

If you joined us for a workshop or session this weekend, we hope you enjoyed your time! Two big events took place in between workshops this weekend: the Platform Orientation, and the Welcome Reception. If you missed the Platform Orientation and you’d like some tips on navigating the meeting platform, check out this video

The Welcome Reception took place on Sunday, and included remarkable performances from UK artists The Ayoub Sisters, the Northern Chamber Orchestra, and Welsh Men’s Choir Only Men Aloud. Following the musical performances, attendees enjoyed interactive demonstrations from Creative Wellness and UK magician Duncan William— we hope you enjoyed yourself as much as we did!

The Day One agenda starts with the Opening Ceremony, which kicks off the Annual Meeting Plenaries and Panels. Join us at 07:45 (UTC) to catch a presentation from keynote speaker, Dr. June Raine CBE, Chief Executive, Medicines and Healthcare Products Regulatory Agency. Judy’s extensive experience includes chairing the European Pharmacovigilance Risk Assessment Committee (PRAC) on behalf of the European Medicines Agency for six years, and serving as a member of the WHO Advisory Committee on Safety of Medicinal Products. Read more about Dr. Raine here.

Plenary One, Evidence for HTA: Innovative Methods for Challenging Times, follows immediately at 09:00 (UTC). The plenary discussion will explore how to drive forward ongoing debate on how the evidence eco-system is, and should continue, changing and adapting to meet the HTA challenges of today, and tomorrow. The Plenary panel includes:

  • Prof. Tracy Merlin | Director, Adelaide Health Technology Assessment (AHTA); Head, School of Public Health, University of Adelaide | Australia
  • Dr. Anna Gagliardi | Senior Scientist / Professor, University Health Network / University of Toronto | Canada
  • Prof. Martin Landray MB ChB PhD FRCP | Professor of Medicine & Epidemiology, Nuffield Department of Population Health / Deputy Director, Big Data Institute, University of Oxford | United Kingdom
  • Prof. Hywel Williams | Scientific and Coordinating Centre Programmes Contracts Advisor, NIHR | United Kingdom

Read more about Plenary 1 here, and the speakers here.

Don’t forget to check out Symposia 1, Tumor Agnostic Medicines for Rare Genomic Alterations: Meeting the HTA and Market Access Challenges, at 14:30 (UTC)! The symposium is presented by Bauer AG and will highlight the value of precision oncology medicines (POMs) and tumor-agnostic drugs (TADs), evaluate response rate as an alternative endpoint for economic modeling (e.g., when overall survival [OS] is unavailable), and discuss considerations and challenges when comparing highly selective versus multi-targeted POMs/TADs. Read more here.

See you at the Opening Ceremony!